RYTM - Rhythm Pharmaceuticals GAAP EPS of -$0.79 beats by $0.22 revenue of $4.28M misses by $0.48M
- Rhythm Pharmaceuticals press release ( NASDAQ: RYTM ): Q3 GAAP EPS of -$0.79 beats by $0.22 .
- Revenue of $4.28M (+319.6% Y/Y) misses by $0.48M .
- cash, cash equivalents and short-term investments were approximately $347.8 million,
For further details see:
Rhythm Pharmaceuticals GAAP EPS of -$0.79 beats by $0.22, revenue of $4.28M misses by $0.48M